Beyond the Label: AI-Driven Reddit Analysis Unveils Unreported Side Effects of GLP-1 Medications and Their Impact on Physical Performance

The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), has fundamentally altered the landscape of metabolic medicine and weight management. While…